Introduction Radical liver resection is the mainstay therapy for patients with hepatocellular carcinoma (HCC) at the very early and early Barcelona Clinic Liver Cancer (BCLC 0-A) stages (1–3). Although the postoperative 5-year overall survival (OS) of patients with HCC at BCLC stages 0-A is above 75%, nearly half of these patients suffer from the postoperative recurrence within 5 years (4, 5), which is the main cause of their death (6–8).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xiang
Contact Xiang, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack